title: POEMS syndrome: are current diagnostic criteria too exclusive?
authors.affiliation: Dermatology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
authors.forename: Yann
authors.initials: Y
authors.lastname: Charli-Joseph
authors.affiliation: Dermatology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
authors.forename: Mónica
authors.initials: M
authors.lastname: Fernández-Sánchez
authors.affiliation: Pathology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
authors.forename: Marcela
authors.initials: M
authors.lastname: Saeb-Lima
authors.affiliation: Dermatology Department, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico. Electronic address: rocio.orozcot@quetzal.innsz.mx.
authors.forename: Rocío
authors.initials: R
authors.lastname: Orozco-Topete
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001707:Biopsy, Needle; D005871:Castleman Disease / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D016878:POEMS Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D018570:Risk Assessment; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000473:pathology* / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents